NOTICIAS
- Immune cells reveal widespread SMN protein loss in spinal muscular atrophy
- Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses
- Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer
- High-fat diets suppress enzyme in immune cells, promoting fat tissue inflammation in mice
- Computer-designed T-cell receptors boost attacks on cancer and viral targets in early tests
- Newly discovered inflammatory cell signaling could open the door to autoimmune disease treatments
- Immune cells that may help sustain type 1 diabetes attack identified
- Why repeated exposures may make allergies worse
- ‘Plug-and-play’ CAR T technology adapts as cancer changes
- Engineered ‘triple-threat’ immune cells could fight plaque buildup that causes heart attacks and strokes
- Restoring brain immune balance opens new avenue for Alzheimer’s treatment
- Chronic stress may be quietly reshaping your heart
- Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantation
- Scientists solve a 50-year mystery and discover a new human blood group
- How a single viral protein hijacks immune cells to supercharge COVID-19 infection
- B cells may help predict risk of colitis from immunotherapy
PUBLICACIONES
- Immune cells reveal widespread SMN protein loss in spinal muscular atrophy
- Toward precision adjuvant immunotherapy in high-risk clear cell renal cell carcinoma: integrating plasma multiomics with PD-1 blockade
- AdvanTIG-105: a phase I/Ib dose-expansion study of ociperlimab plus tislelizumab with or without chemotherapy in metastatic non-small cell lung cancer and extensive-stage small cell lung cancer
- Prostaglandin D2 production in obese mice is associated with reduced lung inflammation and improved control of Francisella tularensis and Bordetella pertussis infection
- Treg dysregulation in the oxidative lung milieu: an emerging mechanistic link in interstitial lung disease associated with systemic autoimmune rheumatic diseases
- IL-13 and skin fibrosis in inflammatory skin diseases
- Correction: Targeting PDPN enhances antitumor T-cell activity by disrupting β-catenin-mediated PD-L1 expression in melanoma
- Recent advances in tumor-activated prodrug nanoparticles for cancer immunotherapy
- Immunometabolic programming of macrophages and tumor-associated macrophages: metabolic pathways shaping polarization, immune regulation, and disease outcomes
- Adjuvant immunotherapy versus observation after neoadjuvant therapy and esophagectomy for esophageal cancer with residual pathologic disease: a systematic review and reconstructed individual participant data meta-analysis
- Biparatopic targeting of CD38 using CD38-specific trimeric antibody recruiters improves cytotoxicity against multiple myeloma
- Multimodal characterization of HLA-G expression across solid tumors reveals transcript-protein discordance and implications for immunotherapy targeting
- Ulcerative colitis, but not Crohn’s disease, displays demographically and clinically driven mucosal immune heterogeneity: implications for patient stratification
- Integrative transcriptomics–metabolomics reveals sphingolipid metabolic reprogramming in traditional Chinese medicine syndrome differentiation of rheumatoid arthritis
- Case Report: Unplanned pregnancy during treatment with inebilizumab in patients with AQP4-IgG-seropositive NMOSD: report of two cases
- Real-world outcomes of atezolizumab–bevacizumab and durvalumab–tremelimumab in unresectable hepatocellular carcinoma: a systematic review with covariate-adjusted meta-regression and exploratory machine learning analysis
- Maternal rubella immunity gaps in the vaccine era: a seroepidemiological study of pregnant women in Jiangsu, China
- Evaluating Fc-mediated antibody functions against SARS-CoV-2 in PLHIV: reduced FcγRIIIa-dependent activity and ADCC despite preserved neutralising antibodies
- Short term ex vivo graft conditioning with venetoclax, fluticasone propionate, and IL-2 reduces graft versus host disease in mouse allogeneic hematopoietic cell transplantation
- Neoadjuvant serplulimab combined with chemotherapy in locally advanced driver gene-negative squamous NSCLC: a multicenter observational study
- When too late is too late: timing of CAR T-cell therapy in SLE & lupus nephritis
- Case Report: Primary aldosteronism coexisting with adrenal insufficiency in a 73-year-old woman with paradoxical hyponatremia
- ZBP1 contributes to IFN-β-induced PANoptosis-related skeletal muscle cell injury in dermatomyositis
- Periodic fever, aphthous stomatitis, pharyngitis, adenitis: clinical manifestations, response to steroids, and a practice of online diagnosis and follow-up
- Triple immunotherapy containing telitacicept for systemic lupus erythematosus complicated by multiple autoimmune diseases: a case report
- Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
- Pantetheinase Vanin-1 potentiates agonist-induced STING activation via S-cysteaminylation
- Case Report: dupilumab for severe pruritus in pediatric recessive dystrophic epidermolysis bullosa—a longitudinal clinical assessment and literature review
- Scoping review: biomarkers in chronic inducible urticaria
- Editorial: Inflammation as a fundamental mechanism of stroke
- Affinity and costimulatory architecture-associated toxicity in mesothelin-targeted TCR-mimetic CAR-T cells
- Transient short-chain fatty acid exposure and the temporal question of epithelial barrier immunity